Go Beyond Cold Storage with VP.S ENCORE^®

Support donor heart viability during organ recovery and transport with VP.S ENCORE^®, an effortlessly portable, easy-to-use hypothermic oxygenated perfusion device.

Where Today’s Preservation Falls Short

Current preservation methods can leave transplant teams balancing narrow timelines against added system complexity.

Driven by Science. Guided by Urgency.

VP.S ENCORE^® was developed in response to these challenges, with a focus on transport, workflow simplicity, and donor heart preservation beyond standard cold storage.

VP.S ENCORE^®: Built for the Demands of Transplant Care

VP.S ENCORE^® is a hypothermic oxygenated perfusion device for donor heart recovery and transport.

The system operates without blood or blood products, using FDA-cleared perfusate and passive cooling in a compact, portable design.

Viability Window

Designed to support organ preservation for up to 8 hours.

Portability

Lightweight and easily transportable by air

Ease of Transport

Designed for single-person transportation

Preservation Requirements

No blood or blood products needed

System Setup

Quick and simple setup

Meet the Future of Organ Preservation

Powered by passive cooling, VP.S ENCORE^® maintains controlled perfusion and continuous preservation during transport across greater distances. In case circulation is disrupted, its built-in cold storage fallback system helps protect the life-saving organ and minimizes ischemic risk.

Preclinical Research Signals

Preclinical findings have shown encouraging signals across porcine, pediatric, and human cardiac models. VP.S ENCORE^® has undergone preclinical testing on more than 100 hearts and received FDA Breakthrough Device Designation in 2021.

Longer Preservation

Up to 24 hours of successful preservation in porcine models

Adequate Lactate Levels

Supports greater organ viability and fitness for use

No Edema Observed

Across porcine, adult human, and pediatric hearts

Please note: VP.S ENCORE^® is in development and is not FDA cleared or approved.

Advancing New Frontiers in Perfusion for Cardiac Surgery

Grant-supported initiatives are advancing new applications for perfusion technology across organ banking, gene therapy, pediatrics, kidney preservation, and vascularized composite tissue research.

Explore VP.S ENCORE^® for Transplant Teams

Connect with our team to learn more about VP.S ENCORE^®, transplant center solutions in development, or opportunities related to future clinical evaluation.

Go Beyond Cold Storage with VP.S ENCORE®